The trial aims to establish clinical proof-of-concept in psoriasis and proof-of-mechanism for other CCR6- and Th17-associated autoimmune indicationsAllschwil, Switzerland - January 6, 2026 ...
The trial aims to establish clinical proof-of-concept in psoriasis and proof-of-mechanism for other CCR6- and Th17-associated autoimmune indications Allschwil, Switzerland - January 6, 2026Idorsia ...
Introduction After the WHO prequalified the first vaccine against mpox, we aimed to identify the influence of vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback